Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
heart failure
Biotech
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
A new analysis from Cytokinetics gives the first shot at a direct comparison between aficamten and BMS’ $13.1 billion heart disease drug Camzyos.
Nick Paul Taylor
May 13, 2024 9:36am
Exo brings AI heart, lung apps to its hand-held ultrasound probe
Apr 24, 2024 9:10am
FDA clears Eko stethoscope AI to catch low ejection fraction
Apr 2, 2024 8:00am
Novo Nordisk inks $1B buyout to pump up heart failure plans
Mar 25, 2024 7:20am
Tenaya's cardiac gene therapy boosts long-term survival in mice
Mar 18, 2024 2:33pm
Abbott recalls HeartMate LVAD communication software
Mar 12, 2024 10:25am